Uzpruvo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Uzpruvo, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: EMA Authorised: Uzpruvo (ustekinumab) — Stada Arzneimittel AG
1 regulatory and trial event tracked for Uzpruvo, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: EMA Authorised: Uzpruvo (ustekinumab) — Stada Arzneimittel AG